Abstract
Introduction: the use of platinum salts in oncological pathologies is widely used, one of the concerns of health professionals is the presence of adverse events in this group of patients who are usually vulnerable, so it is necessary to generate of consensus to make an optimal selection of candidate patients for platinum-based therapies
Objective: To carry out a consensus of experts for the ineligibility for the use of points according to several criteria to carry out an optimal treatment according to the selection and categorization of patients
Health question covered by the Guide: Which patients with otorhinolringological origin cancer are not eligible for treatment with platinums?
Population: The target population is adult patients with ENT cancer.
Results: consensus was established for the ineligibility for the use of lenses on the following criteria: Age> 70 years, ECOG> 1, Involuntary weight loss> 20%, “borderline” hearing function: Grade I alterations, Neurological alterations Grade I, Renal function disorders: CrCL <60 ml / min, Hepatic impairment ? grade II Child-Pugh B, Comorbidities: diabetes, hypertension, pulmonary disorders, anemia and heart failure.Keywords:
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2021 Andrea Paola Moreno Ocampo, Md, Fausto Gady Torres Toala, Jorge Moncayo, Mauricio Riofrío, Eulalia Chusino, Gabriela Loor, Alexandra Peralta, Patricia Guarnizo, Mariuxi Mendoza, Miriam Arguello, Paulina Irigoyen